TMTransMedics TMDX · NASDAQ
$71.60 +1.16% (+$0.82)
- Market cap
- $2.45B
- Enterprise value
- $2.85B
- P/E
- 16.2x
- Forward P/E
- 42.1x
- PEG
- 0.0x
- P/S
- 3.7x
- P/FCF
- 31.1x
- EV/EBITDA
- 23.7x
- ROIC
- 12.3%
- Gross margin
- 58.7%
- Net margin
- 22.7%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 3.3x
- Beta
- 1.93
- Free float
- 96.8%
About the company
TransMedics Group, Inc. (TMDX) is an American company specializing in the development and manufacturing of innovative medical devices for organ transplantation. With the aim of improving the preservation and transportation of organs intended for transplantation, TransMedics has developed the Organ Care System (OCS) technology. This technology allows organs to be maintained in optimal condition during transportation, potentially increasing the success of transplant procedures. The company is known for its commitment to saving lives and innovations in the field of organ transplantation. TransMedics Group, Inc. (TMDX) shares could be suitable for investors looking to invest in a company actively supporting medical research and life-saving through organ transplantation.
Sector
Healthcare
Industry
Medical - Devices
CEO
Waleed H. Hassanein
Employees
898
Headquarters
Andover
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number